Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma

British Journal of Cancer

Volumn 78, Issue 1, 1998, Pages 40-45

  Franzke, A ^a   Probst Kepper, M ^a   Buer, J ^a   Duensing, S ^a   Hoffmann, R ^a   Wittke, F ^a   Volkenandt, M ^b   Ganser, A ^a   Atzpodien, J ^a,c  

^a Dept of Hematology and Oncology

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cutaneous malignant melanoma; Predictor; Soluble vascular cell adhesion molecule

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RISK; STATISTICAL MODEL;

EID: 0031806850     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.439     Document Type: Article

References (30)

1. Albelda SM (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68: 5-17
2. Altomonte M, Colizzi F, Esposito G and Maio M (1992) Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 327: 959
3. Atzpodien J, Lopez Hänninen E, Kirchner H, Franzke A, Körfer A, Volkenandt M, Duensing S, Schomburg A, Chaitchik S and Poliwoda H (1995) Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous Interleukin-2 and Interferon-a after intravenous dacarbazine, cisplatin, carmustine and Tamoxifen. Eur J Cancer 31A: 876-881
4. Balch CM, Soong SJ, Murad TM, Smith JW, Maddox WA and Durant JR (1983) A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1: 126-134
5. Banks RE, Gearing AJH, Hemingway IK, Norfolk DR, Perren TJ and Selby PJ (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 68: 122-124
6. Buer J, Probst M, Franzke A, Duensing S, Haindl J, Volkenandt M, Ganser A and Atzpodien J (1997) Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer (in press).
7. Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34: 187-220
8. Fortis C, Galli L, Consogno G, Citterio G, Matteucci P, Scaglietti G and Bucci E (1995) Serum levels of soluble cell adhesion molecules (ICAM-1, VCAM-1, E-Selectin) and of cytokine TNF-α increase during interleukin-2 therapy. Clin Immunol Immunopathol 75: 142-147
9. Frenette PS and Wagner DD (1996) Adhesion molecules - part I. New Engl J Med 334: 1526-1529
10. Garofalo A, Chirivi RGS, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, Anichini A, Gearing AJ, Sanchez-Madrid F, Dejana E and Giavazzi R (1995) Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastasis. Cancer Res 55: 414-419
11. Gearing ALH and Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14: 506-512
12. Glass AG and Hoover RN (1989) The emerging epidemic of melanoma and squamous cell cancer. JAMA 262: 2097-2100
13. Grin-Jorgensen CM, Rigel DS, Friedman RJ (1992) The worldwide incidence of malignant melanoma. In Cutaneous Melanoma, Balch MB, Houghton AN, Milton GW, Sober AJ, Soong SJ (eds), pp. 27-39. JB Lippincott: Philadelphia
14. Harning R, Mainolfi E, Bystryn J-C, Henn M, Merluzzi VJ and Rothlein R (1991) Serum level of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 51: 5003-5005
15. Heimdal K, Hannisdal E and Gunderson S (1989) Metastatic malignant melanoma. Eur J Cancer 25: 1219-1223
16. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
17. Karlsson M, Jungnelius U, Aamdal S, Boeryd B, Carstensen J and Kågedal B (1996) Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma. Int J Cancer 65: 1-5
18. Koh HK (1991) Cutaneous melanoma. N Engl J Med 325: 171-182
19. Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen HV, Volkenandt M, Ganser A and Atzpodien J (1996) Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 88: 590-594
20. Legha SS (1989) Current therapy for malignant melanoma. Semin Oncol 16: 34-44
21. Mould AP, Askari JA, Craig SE, Garratt AN, Clements J and Humphries MJ (1994) Integrin α4β-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J Biol Chem 44: 27224-27230
22. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronisch J and Matthy MA (1993) Soluble E-selectin is found in the supernatant of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150: 644-654
23. Piali L, Fichtel A, Terpe HJ, Imhof BA and Gisler RH (1995) Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med 181: 811-816
24. Pigott R, Dillon LP, Hemingway ICH and Gearing AJH (1992) Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine-activated endothelial cells. Biochem Biophys Res Commun 187: 584-589
25. Rice GE, Belivacqua MP (1989) An inducible endothelial cell surface glycoprotein mediates adhesion. Science 246: 1303-1306
26. Schadendorf D, Heidel J, Gawilk C, Suter L and Czarnetzki BM (1995) Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 87: 366-371
27. Sirott MN, Bajorin DF, Wong GYN, Tao Y, Chapman PB, Templeton MA and Houghton AN (1993) Prognostic factors in patients with metastatic malignant melanoma. Cancer 72: 3091-3098
28. Smith H, Selby P, Southgate J, Pittman K, Bradley C and Blair GF (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1279
29. Trent JM, Meyskens FL, Salmon SE, Ryschon K, Leong SPL, Davis JR and McGee DL (1990) Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. New Engl J Med 322: 1508-1511
30. Xerri L, Grob JJ, Battyani Z, Gouvernet J, Hassoun J and Bonerandi JJ (1994) NM23 expression in metastasis of malignant melanoma is predictive prognostic parameter correlated with survival. Br J Cancer 70: 1224-1228